Our main interest is to understand how tumor cells respond to cancer therapy. We explore molecular mechanisms behind cancer pathogenesis and therapy response, and search for biomarkers, which could be used as prognostic and/or predictive factors for treatment and survival. Furthermore, we perform clinical trials based on the generated translational data. Our cancer model is lymphoma.
Lymphoma biology and survival
Lymphoid malignancies are a heterogeneous group of cancers that differ significantly in occurrence, risk factors, cell of origin, and...
The Leppä group consists of a multidisciplinary group of skilled and motivated scientists and supportive personnel.